Jallal Bahija, CEO of Immunocore Holdings plc ($IMCR), made one open market sale of company shares in the last 365 days, totaling $371 thousand with the most recent on February 18, 2026. His sales volume ranks 7,116th among 11,678 insiders in the database, well below the average of 8.6 million per seller across 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | M | Ordinary Shares | 23817 | $0.00 | 23,817.0000 | 50,403,717 | 9999.99% | 0.05% |
| Feb. 17, 2026 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | A | Employee Share Option (Right to Buy) | 395066 | $0.00 | 395,066.0000 | 50,403,717 | 9999.99% | 0.78% |
| Feb. 17, 2026 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | A | Restricted Share Units | 88573 | $0.00 | 88,573.0000 | 50,403,717 | 9999.99% | 0.18% |
| Feb. 17, 2026 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | M | Restricted Share Units | 23817 | $0.00 | 71,453.0000 | 50,403,717 | 25.00% | 0.05% |
| Feb. 18, 2026 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | S | Ordinary Shares | 11474 | $32.35 | 12,343.0000 | 50,403,717 | 48.18% | 0.02% |
| May 14, 2025 | Elevance Health, Inc. | $ELV | Jallal Bahija | Director | A | Common Stock | 601 | $0.00 | 4,788.0000 | 232,900,000 | 14.35% | 0.00% |
| Feb. 17, 2025 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | A | Restricted Share Units | 95270 | $0.00 | 95,270.0000 | 49,991,064 | 9999.99% | 0.19% |
| Feb. 17, 2025 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | A | Employee Share Option (Right to Buy) | 405824 | $0.00 | 405,824.0000 | 49,991,064 | 9999.99% | 0.81% |
| May 15, 2024 | Elevance Health, Inc. | $ELV | Jallal Bahija | Director | A | Common Stock | 388 | $0.00 | 4,187.0000 | 237,400,000 | 10.21% | 0.00% |
| Feb. 16, 2024 | Immunocore Holdings plc | $IMCR | Jallal Bahija | CHIEF EXECUTIVE OFFICER | A | Employee Share Option (Right to Buy) | 281819 | $0.00 | 281,819.0000 | 48,888,975 | 9999.99% | 0.58% |
| Jan. 25, 2024 | ArriVent BioPharma, Inc. | $AVBP | Jallal Bahija | Director | A | Stock Option (right to buy) | 17884 | $0.00 | 17,884.0000 | 2,140,951 | 9999.99% | 0.84% |
| May 10, 2023 | Elevance Health, Inc. | $ELV | Jallal Bahija | Director | A | Common Stock | 457 | $0.00 | 3,799.0000 | 242,800,000 | 13.67% | 0.00% |